Quick Answer
Nuo Therapeutics, Inc. reported Common Stock Shares Outstanding of 48.18 million shares for the year ending 2025.
- Nuo Therapeutics, Inc. showed an increase of +2.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Nuo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2010 to 2025 (22 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: 51.95 million shares | Q3 2011: 52.76 million shares | Q1 2012: 70.91 million shares | Q2 2012: 90.69 million shares | Q3 2012: 91.48 million shares | Q1 2013: 104.34 million shares | Q2 2013: 104.78 million shares | Q3 2013: 105.19 million shares | Q1 2014: 121.33 million shares | Q2 2014: 121.70 million shares | Q3 2014: 124.41 million shares | Q1 2015: 125.68 million shares | Q2 2015: 125.68 million shares | Q3 2015: 125.68 million shares | Q1 2016: 125.68 million shares | Q2 2016: 9.93 million shares | Q3 2016: 9.93 million shares | Q1 2017: 9.93 million shares | Q2 2017: 9.93 million shares | Q3 2017: 22.73 million shares | Q1 2018: 22.72 million shares | Q2 2018: 23.72 million shares | Q3 2018: 23.72 million shares | Q4 2018: 23.72 million shares | Q1 2019: 23.72 million shares | Q2 2019: 23.72 million shares | Q3 2019: 23.72 million shares | Q4 2020: 30.26 million shares | Q3 2021: 30.26 million shares | Q1 2022: 37.12 million shares | Q2 2022: 41.08 million shares | Q3 2022: 41.80 million shares | Q1 2023: 41.80 million shares | Q2 2023: 41.80 million shares | Q3 2023: 42.32 million shares | Q1 2024: 44.24 million shares | Q2 2024: 45.47 million shares | Q3 2024: 46.60 million shares | Q1 2025: 46.82 million shares | Q2 2025: 46.83 million shares | Q3 2025: 47.88 million shares.
- Over the full 22 years of available data (2010 to 2025), Nuo Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 9.2%.
- Historical annual values: Fiscal year 2025: 48.18 million shares | Fiscal year 2024: 46.82 million shares | Fiscal year 2023: 44.24 million shares | Fiscal year 2022: 41.80 million shares | Fiscal year 2021: 37.12 million shares | Fiscal year 2021: 30.26 million shares | Fiscal year 2021: 30.26 million shares | Fiscal year 2021: 30.26 million shares | Fiscal year 2020: 30.26 million shares | Fiscal year 2020: 24.25 million shares | Fiscal year 2020: 24.25 million shares | Fiscal year 2020: 24.25 million shares | Fiscal year 2019: 23.72 million shares | Fiscal year 2018: 23.72 million shares | Fiscal year 2017: 22.72 million shares | Fiscal year 2016: 9.93 million shares | Fiscal year 2015: 125.68 million shares | Fiscal year 2014: 125.68 million shares | Fiscal year 2013: 107.16 million shares | Fiscal year 2012: 93.81 million shares | Fiscal year 2011: 55.54 million shares | Fiscal year 2010: 44.10 million shares.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: